Which three fruits are most taboo when taking Upatinib? Complete analysis of dietary taboos

Upadacitinib (Upadacitinib) is a targeted small molecule drug whose metabolic pathway is highly dependent on the liver enzyme system (especially CYP3A4). Its pharmacokinetic characteristics determine that patients must be cautious about their diet while taking the drug. In particular, the interference of certain fruits on the enzyme system may cause abnormal increases or decreases in blood drug concentration, increase the risk of toxic side effects or affect efficacy. Among them, the three most taboo fruits are grapefruit (grapefruit), pomelo and pomegranate. They are all "high-risk fruits" that affect the metabolism of upadatinib.

Grapefruit contains a large amount of furanocoumarins, which are powerful inhibitors of the CYP3A4 enzyme and can significantly inhibit the metabolism of upadatinib in the liver and small intestine, leading to an abnormal increase in the concentration of the drug in the body and increasing the risk of adverse reactions, such as infection, elevated blood lipids, or abnormal liver enzymes. Similar to grapefruit, grapefruit is also rich in natural enzyme inhibitory ingredients. Its mechanism of action is similar to that of grapefruit. It will also slow down the metabolism of upadatinib and cause disorders in blood drug concentration. In addition, although pomegranate is rarely mentioned, recent studies have found that some of its components also have the ability to inhibit the activity of liver metabolic enzymes, which cannot be ignored.

While taking upatinib, in addition to these three fruits, patients should also avoid health drinks containing concentrated fruit juices, such as mixed fruit and vegetable juices or health fruit drinks, because they may contain related enzyme inhibitory substances. The diet should be mainly light, and high-fat and high-sugar foods should be avoided to avoid aggravating the metabolic burden on the liver. If the patient must take food or health products containing enzyme inhibitors while taking medication, it is recommended to consult a doctor or pharmacist in advance to avoid potential drug-food interactions that may have a negative impact on efficacy and safety.

To sum up, patients taking upatinib need to strictly follow dietary guidance, and especially avoid fruits such as grapefruit, pomelo, and pomegranate that may affect drug metabolism to ensure the effectiveness and safety of the treatment.

Reference materials:https://www.rinvoq.com/